Back to Journals » OncoTargets and Therapy » Volume 11

Cardiotoxic effects of the novel approved anti-ErbB2 agents and reverse cardioprotective effects of ranolazine

Total article views   Abstract views HTML views PDF downloads Totals
1,121 Dovepress* 1,034 87+ 251 1,121
Totals 1,034 87 251 1,121
*Since 19 April 2018
+Since July 2016

View citations on Google Scholar